Loading…

Chromatinized Protein Kinase C-θ Directly Regulates Inducible Genes in Epithelial to Mesenchymal Transition and Breast Cancer Stem Cells

Epithelial to mesenchymal transition (EMT) is activated during cancer invasion and metastasis, enriches for cancer stem cells (CSCs), and contributes to therapeutic resistance and disease recurrence. Signal transduction kinases play a pivotal role as chromatin-anchored proteins in eukaryotes. Here w...

Full description

Saved in:
Bibliographic Details
Published in:Molecular and cellular biology 2014-08, Vol.34 (16), p.2961-2980
Main Authors: Zafar, Anjum, Wu, Fan, Hardy, Kristine, Li, Jasmine, Tu, Wen Juan, McCuaig, Robert, Harris, Janelle, Khanna, Kum Kum, Attema, Joanne, Gregory, Philip A., Goodall, Gregory J., Harrington, Kirsti, Dahlstrom, Jane E., Boulding, Tara, Madden, Rebecca, Tan, Abel, Milburn, Peter J., Rao, Sudha
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Epithelial to mesenchymal transition (EMT) is activated during cancer invasion and metastasis, enriches for cancer stem cells (CSCs), and contributes to therapeutic resistance and disease recurrence. Signal transduction kinases play a pivotal role as chromatin-anchored proteins in eukaryotes. Here we report for the first time that protein kinase C-theta (PKC-θ) promotes EMT by acting as a critical chromatin-anchored switch for inducible genes via transforming growth factor β (TGF-β) and the key inflammatory regulatory protein NF-κB. Chromatinized PKC-θ exists as an active transcription complex and is required to establish a permissive chromatin state at signature EMT genes. Genome-wide analysis identifies a unique cohort of inducible PKC-θ-sensitive genes that are directly tethered to PKC-θ in the mesenchymal state. Collectively, we show that cross talk between signaling kinases and chromatin is critical for eliciting inducible transcriptional programs that drive mesenchymal differentiation and CSC formation, providing novel mechanisms to target using epigenetic therapy in breast cancer.
ISSN:1098-5549
0270-7306
1098-5549
DOI:10.1128/MCB.01693-13